Authors:
ZEIS M
UHAREK L
PETRELLA E
GLASS B
STEINMANN J
SCHMITZ N
Citation: M. Zeis et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNITY IN MURINE STEM-CELL DONORS, Bone marrow transplantation, 21, 1998, pp. 239-239
Authors:
UHAREK L
ZEIS M
PETRELLA E
GLASS B
STEINMANN J
KRONKE M
SCHMITZ N
Citation: L. Uharek et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNE REACTIVITY IN ALLOGENEIC MURINE STEM-CELL DONORS, British Journal of Haematology, 102(1), 1998, pp. 83-83
Authors:
REDALIEU E
THOMPSON RG
DEAN E
PETRELLA E
MUSUNURI S
GOTTLIEB A
KOLTERMAN OG
Citation: E. Redalieu et al., PHARMACOKINETICS OF PRAMLINTIDE AND FREE-INSULIN FOLLOWING COMBINED OR SEPARATE INJECTIONS IN PATIENTS WITH TYPE-I DIABETES, Diabetes, 45, 1996, pp. 808-808
Authors:
KUUSREICHEL K
KNOTT C
SAMFONG P
PETRELLA E
CORVALAN JRF
Citation: K. Kuusreichel et al., THERAPY OF STREPTOZOTOCIN-INDUCED DIABETES WITH A BIFUNCTIONAL ANTIBODY THAT DELIVERS VINCA ALKALOIDS TO IL-2 RECEPTOR-POSITIVE CELLS, Autoimmunity, 22(3), 1995, pp. 173-181